Quanguang Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Quanguang Zhang has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
Yan Dong
Department of Neuroscience and Regenerative Medicine, Medical College of Georgia, Augusta University, Augusta, GA, USA
6 shared publicationsNingjun Zhao
Institute of Emergency and Rescue medicine, Xuzhou Medical University, Xuzhou, Jiangsu province, China
4 shared publicationsDong Han
Institute of Emergency and Rescue medicine, Xuzhou Medical University, Xuzhou, Jiangsu province, China
3 shared publicationsDonovan Tucker
Department of Neuroscience and Regenerative Medicine, Medical College of Georgia, Augusta University, Augusta, GA, USA
3 shared publicationsTimon Cheng-Yi Liu
3 shared publications- Darrell W. Brann
Institute of Molecular Medicine and Genetics, Georgia Regents University, Augusta, GA 30912, USA
2 shared publications
Latest Publications
- Open Access
- 4 October 2018
- Published by Universite Catholique de Louvain in Exercise Biochemistry Review
- Vol. 1 (5)
PO-239 Normal signal transduction pathways of rat habitual endurance exercise at different intensities
Objective A signal transduction pathway is always signal-specific, but it becomes special in exercise physiology, especially for habitual exercise training. In this paper, the normal signal transduction pathways (NPs) of habitual endurance exercise of Sprague-Dawly (SD) rats at different intensities were studied in terms of self-similar algorithm . Methods 1. SD rats were randomly divided into a control group with no exercise (Cont), a low-intensity exercise group (LI) at 15 m/min for 60 min, a medium-intensity exercise group (MI) at 25 m/min for 40 min, and a high-intensity exercise group (HI) 35 m/min for 30 min. The the treadmill exercise began at 10 m/min for 10 min. The speed and time increased by 5 m/min and by 5 min respectively after every two days until the intensity was OK for LI, MI and HI groups. All rats in the exercise groups were trained for eight weeks. The muscle was collected two hours after the last training. The 20 parameters, the expression of PGC-1α, PI3K, AMPK, p38MAPK, SIRT1, IGF-1, Akt, mTOR, TFAM, NRF1 and NRF2 and the level of T, CS, SDH, β-HAD, MDH, HK, PK, LDH and HSL, were assessed. 2. The 20 dimension data sets were integratedly analyzed with self-similar algorithm. Results 1. The first-order self-similarity held for the 20 dimension data sets between MI and HI groups. 2. There was one biomarker, PGC-1α, between Cont and LI groups with respect to HI group which parameters were used to be dimensionless for Cont and LI groups. 3. There were two biomarkers, PGC-1α and PI3K, between LI and MI or HI groups with respect cont group. Conclusions The NP of LI group may be PGC-1α pathway, and the NPs of MI or HI group may be PGC-1α and PI3K pathways.
- 4 October 2018
- Published by Universite Catholique de Louvain in Exercise Biochemistry Review
- Vol. 1 (5)
Open AccessPO-239 Normal signal transduction pathways of rat habitual endurance exercise at different intensities
Objective A signal transduction pathway is always signal-specific, but it becomes special in exercise physiology, especially for habitual exercise training. In this paper, the normal signal transduction pathways (NPs) of habitual endurance exercise of Sprague-Dawly (SD) rats at different intensities were studied in terms of self-similar algorithm . Methods 1. SD rats were randomly divided into a control group with no exercise (Cont), a low-intensity exercise group (LI) at 15 m/min for 60 min, a medium-intensity exercise group (MI) at 25 m/min for 40 min, and a high-intensity exercise group (HI) 35 m/min for 30 min. The the treadmill exercise began at 10 m/min for 10 min. The speed and time increased by 5 m/min and by 5 min respectively after every two days until the intensity was OK for LI, MI and HI groups. All rats in the exercise groups were trained for eight weeks. The muscle was collected two hours after the last training. The 20 parameters, the expression of PGC-1α, PI3K, AMPK, p38MAPK, SIRT1, IGF-1, Akt, mTOR, TFAM, NRF1 and NRF2 and the level of T, CS, SDH, β-HAD, MDH, HK, PK, LDH and HSL, were assessed. 2. The 20 dimension data sets were integratedly analyzed with self-similar algorithm. Results 1. The first-order self-similarity held for the 20 dimension data sets between MI and HI groups. 2. There was one biomarker, PGC-1α, between Cont and LI groups with respect to HI group which parameters were used to be dimensionless for Cont and LI groups. 3. There were two biomarkers, PGC-1α and PI3K, between LI and MI or HI groups with respect cont group. Conclusions The NP of LI group may be PGC-1α pathway, and the NPs of MI or HI group may be PGC-1α and PI3K pathways.
- Open Access
- 4 October 2018
- Published by Universite Catholique de Louvain in Exercise Biochemistry Review
- Vol. 1 (2)
OR-056 No cardiovascular responses to energy drink consumption in young healthy adult
Objective Svatikova et al. (2015) in JAMA have conducted a randomized trial of cardiovascular responses to energy drink consumption in healthy adults, and found it significantly increased levels of blood pressure and catecholamines in young healthy adults. Their data were re-analyzed in terms of fractal self-similarity and quantitative difference (QD) in this paper. Methods 1. The logarithm to base golden section τ (lt) is called golden logarithm. It was found that σ=ltσ ≈ 0.710439287156503. 2. For a process from x1 to x2, lx(1,2)=lt(x2/x1) and its absolute vale are called the process logarithm and its QD, QDx(1,2). There are QD threshold values (αx,βx,γx) of function x which can be calculated in terms of σ. The function x is kept to be constant if QDx(1,2) < αx. A function in/far from its function-specific homeostasis is called a normal/dysfunctional function. A normal function can resist a disturbance under its threshold so that QDx(1,2) < βx. A dysfunctional function is defined as the QD is significant if βx ≦QDx(1,2) < γx and extraordinarily significant if QDx(1,2) ≧ γx. 3. Self-similarity was studied in the fractal literature: a pattern is self-similar if it does not vary with spatial or temporal scale. First-order self-similarity condition leads to the power law between two data sets A = {xi} and B = {yi}; yi = ai xi if the QDi of ai and the average of {ai} is smaller than βmin=min{βi} and the average QD of {QDi} is smaller than αmin=min{αi}. 4. The σ algorithm for integrative biology was established based on high-order self-similarity. Results The 18 dimension data set consisted of all the 18 parameters. The first-order self-similarity held for the 18 dimension data sets between after and before for placebo or energy drink, and between placebo and energy drink for the 18 dimension ratio data set of after to before. Conclusions There may be no cardiovascular responses to energy drink consumption in young healthy adult.
- 4 October 2018
- Published by Universite Catholique de Louvain in Exercise Biochemistry Review
- Vol. 1 (2)
Open AccessOR-056 No cardiovascular responses to energy drink consumption in young healthy adult
Objective Svatikova et al. (2015) in JAMA have conducted a randomized trial of cardiovascular responses to energy drink consumption in healthy adults, and found it significantly increased levels of blood pressure and catecholamines in young healthy adults. Their data were re-analyzed in terms of fractal self-similarity and quantitative difference (QD) in this paper. Methods 1. The logarithm to base golden section τ (lt) is called golden logarithm. It was found that σ=ltσ ≈ 0.710439287156503. 2. For a process from x1 to x2, lx(1,2)=lt(x2/x1) and its absolute vale are called the process logarithm and its QD, QDx(1,2). There are QD threshold values (αx,βx,γx) of function x which can be calculated in terms of σ. The function x is kept to be constant if QDx(1,2) < αx. A function in/far from its function-specific homeostasis is called a normal/dysfunctional function. A normal function can resist a disturbance under its threshold so that QDx(1,2) < βx. A dysfunctional function is defined as the QD is significant if βx ≦QDx(1,2) < γx and extraordinarily significant if QDx(1,2) ≧ γx. 3. Self-similarity was studied in the fractal literature: a pattern is self-similar if it does not vary with spatial or temporal scale. First-order self-similarity condition leads to the power law between two data sets A = {xi} and B = {yi}; yi = ai xi if the QDi of ai and the average of {ai} is smaller than βmin=min{βi} and the average QD of {QDi} is smaller than αmin=min{αi}. 4. The σ algorithm for integrative biology was established based on high-order self-similarity. Results The 18 dimension data set consisted of all the 18 parameters. The first-order self-similarity held for the 18 dimension data sets between after and before for placebo or energy drink, and between placebo and energy drink for the 18 dimension ratio data set of after to before. Conclusions There may be no cardiovascular responses to energy drink consumption in young healthy adult.
- Open Access
- 19 November 2017
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 122 (5) , 470-480
After Treatment with Methylene Blue is Effective against Delayed Encephalopathy after Acute Carbon Monoxide Poisoning
Delayed encephalopathy after acute carbon monoxide (CO) poisoning (DEACMP) is the most severe and clinically intractable complication that occurs following acute CO poisoning. Unfortunately, the mechanism ofDEACMPis still vague. Growing evidence indicates that delayed cerebral damage afterCOpoisoning is related to oxidative stress, abnormal neuro‐inflammation, apoptosis and immune‐mediated injury. Our recent report indicated that methylene blue (MB) may be a promising therapeutic agent in the prevention of neuronal cell death and cognitive deficits after transient global cerebral ischaemia (GCI). In this study, we aimed to investigate the potential ofMBtherapy to ameliorate the signs and symptoms of DEACMP. Rats were exposed to 1000 ppmCOfor 40 min. in the first step;COwas then increased to 3000 ppm, which was maintained for another 20 min. The rats were implanted with 7‐day release Alzet osmotic mini‐pumps subcutaneously under the back skin, which providedMBat a dose of 0.5 mg/kg/day 1 hr afterCOexposure. The results showed thatMBsignificantly suppressed oxidative damage and expression of pro‐inflammatory factors, including tumour necrosis factor‐α and interleukin (IL)‐1β.MBtreatment also suitably modulated mitochondrial fission and fusion, which is helpful in the preservation of mitochondrial function. Furthermore,MBdramatically attenuated apoptosis and neuronal death. Lastly, behavioural studies revealed thatMBtreatment preserved spatial learning and memory in the Barnes maze test. Our findings indicated thatMBmay have protective effects against DEACMP.
- 19 November 2017
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 122 (5) , 470-480
Open AccessAfter Treatment with Methylene Blue is Effective against Delayed Encephalopathy after Acute Carbon Monoxide Poisoning
Delayed encephalopathy after acute carbon monoxide (CO) poisoning (DEACMP) is the most severe and clinically intractable complication that occurs following acute CO poisoning. Unfortunately, the mechanism ofDEACMPis still vague. Growing evidence indicates that delayed cerebral damage afterCOpoisoning is related to oxidative stress, abnormal neuro‐inflammation, apoptosis and immune‐mediated injury. Our recent report indicated that methylene blue (MB) may be a promising therapeutic agent in the prevention of neuronal cell death and cognitive deficits after transient global cerebral ischaemia (GCI). In this study, we aimed to investigate the potential ofMBtherapy to ameliorate the signs and symptoms of DEACMP. Rats were exposed to 1000 ppmCOfor 40 min. in the first step;COwas then increased to 3000 ppm, which was maintained for another 20 min. The rats were implanted with 7‐day release Alzet osmotic mini‐pumps subcutaneously under the back skin, which providedMBat a dose of 0.5 mg/kg/day 1 hr afterCOexposure. The results showed thatMBsignificantly suppressed oxidative damage and expression of pro‐inflammatory factors, including tumour necrosis factor‐α and interleukin (IL)‐1β.MBtreatment also suitably modulated mitochondrial fission and fusion, which is helpful in the preservation of mitochondrial function. Furthermore,MBdramatically attenuated apoptosis and neuronal death. Lastly, behavioural studies revealed thatMBtreatment preserved spatial learning and memory in the Barnes maze test. Our findings indicated thatMBmay have protective effects against DEACMP.
- 1 January 2017
- Published by Elsevier in Neurobiology of Aging
- Vol. 49, 165-182
Low-level laser therapy for beta amyloid toxicity in rat hippocampus
- 1 January 2017
- Published by Elsevier in Neurobiology of Aging
- Vol. 49, 165-182
Low-level laser therapy for beta amyloid toxicity in rat hippocampus
- Open Access
- 9 December 2015
- Vol. 2 (1) , 1-14
Role of Mitochondria in Neonatal Hypoxic-Ischemic Brain Injury
Hypoxic-ischemia (HI) causes severe brain injury in neonates. It’s one of the leading causes to neonatal death and pediatric disability, resulting in devastating consequences, emotionally and economically, to their families. A series of events happens in this process, e.g. excitatory transmitter release, extracelluar Ca2+ influxing, mitochondrial dysfunction, energy failure, and neuron death. There are two forms of neuron death after HI insult: necrosis and apoptosis, apoptosis being the more prevalent form. Mitochondria handle a series of oxidative reactions, and yield energy for various cellular activities including the maintainance of membrane potential and preservation of intracellular ionic homeostasis. Therefore mitochondria play a critical role in neonatal neurodegeneration following HI, and mitochondrial dysfunction is the key point in neurodegenerative evolution. Because of this, exploring effective mitochondria-based clinical strategies is crucial. Today the only efficacious clinic treatment is hypothermia. However, due to its complex management, clinical complication and autoimmune decrease, its clinical application is limited. So far, many mitochondria-based strategies have been reported neuroprotective in animal models, which offers promise on neonatal therapy. However, since their clinical effectiveness are still unclear, plenty of studies need to be continued in the future. According to recent reports, two novel strategies have been proposed: methylene blue (MB) and melatonin. Although they are still in primary stage, the underlying mechanisms indicate promising clinical applications. Every neurological therapeutic strategy has its intrinsic deficit and limited efficacy, therefore in the long run, the perfect clinical therapy for hypoxic-ischemic neonatal brain injury will be based on the combination of multiple strategies.
- 9 December 2015
- Vol. 2 (1) , 1-14
Open AccessRole of Mitochondria in Neonatal Hypoxic-Ischemic Brain Injury
Hypoxic-ischemia (HI) causes severe brain injury in neonates. It’s one of the leading causes to neonatal death and pediatric disability, resulting in devastating consequences, emotionally and economically, to their families. A series of events happens in this process, e.g. excitatory transmitter release, extracelluar Ca2+ influxing, mitochondrial dysfunction, energy failure, and neuron death. There are two forms of neuron death after HI insult: necrosis and apoptosis, apoptosis being the more prevalent form. Mitochondria handle a series of oxidative reactions, and yield energy for various cellular activities including the maintainance of membrane potential and preservation of intracellular ionic homeostasis. Therefore mitochondria play a critical role in neonatal neurodegeneration following HI, and mitochondrial dysfunction is the key point in neurodegenerative evolution. Because of this, exploring effective mitochondria-based clinical strategies is crucial. Today the only efficacious clinic treatment is hypothermia. However, due to its complex management, clinical complication and autoimmune decrease, its clinical application is limited. So far, many mitochondria-based strategies have been reported neuroprotective in animal models, which offers promise on neonatal therapy. However, since their clinical effectiveness are still unclear, plenty of studies need to be continued in the future. According to recent reports, two novel strategies have been proposed: methylene blue (MB) and melatonin. Although they are still in primary stage, the underlying mechanisms indicate promising clinical applications. Every neurological therapeutic strategy has its intrinsic deficit and limited efficacy, therefore in the long run, the perfect clinical therapy for hypoxic-ischemic neonatal brain injury will be based on the combination of multiple strategies.
- 3 October 2015
- Published by Springer Nature in Molecular Neurobiology
- Vol. 53 (8) , 5344-5355
Neuroprotective and Functional Improvement Effects of Methylene Blue in Global Cerebral Ischemia
Transient global cerebral ischemia (GCI) causes delayed neuronal cell death in the vulnerable hippocampus CA1 subfield, as well as behavioral deficits. Ischemia reperfusion (I/R) produces excessive reactive oxygen species and plays a key role in brain injury. The mitochondrial electron respiratory chain is the main cellular source of free radical generation, and dysfunction of mitochondria has a significant impact on the neuronal cell death in ischemic brain. The aim of the present study is to investigate the potential beneficial effects of methylene blue (MB) in a four-vessel occlusion (4VO) GCI model on adult male rats. MB was delivered at a dose of 0.5 mg/kg/day for 7 days, through a mini-pump implanted subcutaneously after GCI. We first found that MB significantly improved ischemic neuronal survival in the hippocampal CA1 region as measured by cresyl violet staining as well as NeuN staining. We also found that MB has the ability to rescue ischemia-induced decreases of cytochrome c oxidase activity and ATP generation in the CA1 region following I/R. Further analysis with labeling of MitoTracker® Red revealed that the depolarization of mitochondrial membrane potential (MMP) was markedly attenuated following MB treatment. In addition, the induction of caspase-3, caspase-8, and caspase-9 activities and the increased numbers of TUNEL-positive cells of the CA1 region were significantly reduced by MB application. Correspondingly, Barnes maze tests showed that the deterioration of spatial learning and memory performance following GCI was significantly improved in the MB-treatment group compared to the ischemic control group. In summary, our study suggests that MB may be a promising therapeutic agent targeting neuronal cell death and cognitive deficits following transient global cerebral ischemia.
- 3 October 2015
- Published by Springer Nature in Molecular Neurobiology
- Vol. 53 (8) , 5344-5355
Neuroprotective and Functional Improvement Effects of Methylene Blue in Global Cerebral Ischemia
Transient global cerebral ischemia (GCI) causes delayed neuronal cell death in the vulnerable hippocampus CA1 subfield, as well as behavioral deficits. Ischemia reperfusion (I/R) produces excessive reactive oxygen species and plays a key role in brain injury. The mitochondrial electron respiratory chain is the main cellular source of free radical generation, and dysfunction of mitochondria has a significant impact on the neuronal cell death in ischemic brain. The aim of the present study is to investigate the potential beneficial effects of methylene blue (MB) in a four-vessel occlusion (4VO) GCI model on adult male rats. MB was delivered at a dose of 0.5 mg/kg/day for 7 days, through a mini-pump implanted subcutaneously after GCI. We first found that MB significantly improved ischemic neuronal survival in the hippocampal CA1 region as measured by cresyl violet staining as well as NeuN staining. We also found that MB has the ability to rescue ischemia-induced decreases of cytochrome c oxidase activity and ATP generation in the CA1 region following I/R. Further analysis with labeling of MitoTracker® Red revealed that the depolarization of mitochondrial membrane potential (MMP) was markedly attenuated following MB treatment. In addition, the induction of caspase-3, caspase-8, and caspase-9 activities and the increased numbers of TUNEL-positive cells of the CA1 region were significantly reduced by MB application. Correspondingly, Barnes maze tests showed that the deterioration of spatial learning and memory performance following GCI was significantly improved in the MB-treatment group compared to the ischemic control group. In summary, our study suggests that MB may be a promising therapeutic agent targeting neuronal cell death and cognitive deficits following transient global cerebral ischemia.
- 1 January 2015
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 400 (C) , 21-31
Attenuation of mitochondrial and nuclear p38α signaling: A novel mechanism of estrogen neuroprotection in cerebral ischemia
- 1 January 2015
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 400 (C) , 21-31
Attenuation of mitochondrial and nuclear p38α signaling: A novel mechanism of estrogen neuroprotection in cerebral ischemia
- Open Access
- 1 January 2015
- Published by Scitechnol Biosoft Pvt. Ltd. in Journal of Neurology and Neuroscience
- Vol. 06 (02)
Mitochondrial Targeted Antioxidant in Cerebral Ischemia
There has been much evidence suggesting that reactive oxygen species (ROS) generated in mitochondria during cerebral ischemia play a major role in programming the senescence of organism. Antioxidants dealing with mitochondria slow down the appearance and progression of symptoms in cerebral ischemia and increase the life span of organisms. The mechanisms of mitochondrial targeted antioxidants, such as SKQ1, Coenzyme Q10, MitoQ, and Methylene blue, include increasing adenosine triphosphate (ATP) production, decreasing production of ROS and increasing antioxidant defenses, providing benefits in neuroprotection following cerebral ischemia. A number of studies have shown the neuroprotective role of these mitochondrial targeted antioxidants in cerebral ischemia. Here in this short review we have compiled the literature supporting consequences of mitochondrial dysfunction, and the protective role of mitochondrial targeted antioxidants.
- 1 January 2015
- Published by Scitechnol Biosoft Pvt. Ltd. in Journal of Neurology and Neuroscience
- Vol. 06 (02)
Open AccessMitochondrial Targeted Antioxidant in Cerebral Ischemia
There has been much evidence suggesting that reactive oxygen species (ROS) generated in mitochondria during cerebral ischemia play a major role in programming the senescence of organism. Antioxidants dealing with mitochondria slow down the appearance and progression of symptoms in cerebral ischemia and increase the life span of organisms. The mechanisms of mitochondrial targeted antioxidants, such as SKQ1, Coenzyme Q10, MitoQ, and Methylene blue, include increasing adenosine triphosphate (ATP) production, decreasing production of ROS and increasing antioxidant defenses, providing benefits in neuroprotection following cerebral ischemia. A number of studies have shown the neuroprotective role of these mitochondrial targeted antioxidants in cerebral ischemia. Here in this short review we have compiled the literature supporting consequences of mitochondrial dysfunction, and the protective role of mitochondrial targeted antioxidants.
- 1 May 2014
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 389 (1-2) , 84-91
Brain-derived estrogen exerts anti-inflammatory and neuroprotective actions in the rat hippocampus
- 1 May 2014
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 389 (1-2) , 84-91
Brain-derived estrogen exerts anti-inflammatory and neuroprotective actions in the rat hippocampus
- Open Access
- 9 March 2013
- Published by Oxford University Press (OUP) in Brain
- Vol. 136 (5) , 1432-1445
Hypersensitivity of the hippocampal CA3 region to stress-induced neurodegeneration and amyloidogenesis in a rat model of surgical menopause
Females who enter menopause prematurely via bilateral ovariectomy (surgical menopause) have a significantly increased risk for cognitive decline and dementia. To help elucidate the mechanisms underlying this phenomenon, we used an animal model of surgical menopause, long-term (10-week) bilateral ovariectomy in female rats. Herein, we demonstrate that long-term oestrogen deprivation dramatically increases sensitivity of the normally resistant hippocampal CA3 region to ischaemic stress, an effect that was gender-specific, as it was not observed in long-term orchiectomized males. Furthermore, the enhanced damage to the CA3 region correlated with a worse cognitive outcome after ischaemic stress. Long-term ovariectomized rats also displayed a robust hyperinduction of Alzheimer’s disease-related proteins in the CA3 region and a switch in amyloid precursor protein processing from non-amyloidogenic to amyloidogenic following ischaemic stress CA3 hypersensitivity also extended to an Alzheimer’s disease-relevant insult, as the CA3 region of long-term ovariectomized rats was profoundly hypersensitive to the neurotoxic effects of amyloid-β1–42, the most amyloidogenic form of the amyloid-β peptide. Additional studies revealed that CA3 region hypersensitivity, Alzheimer’s disease-related protein induction, and amyloidogenesis are mediated by a NADPH oxidase/superoxide/c-Jun N-terminal kinase/c-Jun signalling pathway, involving both transcriptional and post-translational mechanisms. In addition, while 17β-oestradiol replacement at the end of the long-term oestrogen deprivation period could not prevent CA3 hypersensitivity and amyloidogenesis, if 17β-oestradiol was initiated at the time of ovariectomy and maintained throughout the 10-week oestrogen deprivation period, it completely prevented these events, providing support for the ‘critical window’ hypothesis for oestrogen replacement therapy benefit. Collectively, these findings may help explain the increased risk of cognitive decline and dementia observed in women following surgical menopause, and they provide increased support that early 17β-oestradiol replacement is critical in preventing the negative neural effects associated with bilateral ovariectomy.
- 9 March 2013
- Published by Oxford University Press (OUP) in Brain
- Vol. 136 (5) , 1432-1445
Open AccessHypersensitivity of the hippocampal CA3 region to stress-induced neurodegeneration and amyloidogenesis in a rat model of surgical menopause
Females who enter menopause prematurely via bilateral ovariectomy (surgical menopause) have a significantly increased risk for cognitive decline and dementia. To help elucidate the mechanisms underlying this phenomenon, we used an animal model of surgical menopause, long-term (10-week) bilateral ovariectomy in female rats. Herein, we demonstrate that long-term oestrogen deprivation dramatically increases sensitivity of the normally resistant hippocampal CA3 region to ischaemic stress, an effect that was gender-specific, as it was not observed in long-term orchiectomized males. Furthermore, the enhanced damage to the CA3 region correlated with a worse cognitive outcome after ischaemic stress. Long-term ovariectomized rats also displayed a robust hyperinduction of Alzheimer’s disease-related proteins in the CA3 region and a switch in amyloid precursor protein processing from non-amyloidogenic to amyloidogenic following ischaemic stress CA3 hypersensitivity also extended to an Alzheimer’s disease-relevant insult, as the CA3 region of long-term ovariectomized rats was profoundly hypersensitive to the neurotoxic effects of amyloid-β1–42, the most amyloidogenic form of the amyloid-β peptide. Additional studies revealed that CA3 region hypersensitivity, Alzheimer’s disease-related protein induction, and amyloidogenesis are mediated by a NADPH oxidase/superoxide/c-Jun N-terminal kinase/c-Jun signalling pathway, involving both transcriptional and post-translational mechanisms. In addition, while 17β-oestradiol replacement at the end of the long-term oestrogen deprivation period could not prevent CA3 hypersensitivity and amyloidogenesis, if 17β-oestradiol was initiated at the time of ovariectomy and maintained throughout the 10-week oestrogen deprivation period, it completely prevented these events, providing support for the ‘critical window’ hypothesis for oestrogen replacement therapy benefit. Collectively, these findings may help explain the increased risk of cognitive decline and dementia observed in women following surgical menopause, and they provide increased support that early 17β-oestradiol replacement is critical in preventing the negative neural effects associated with bilateral ovariectomy.